|Day's Range||2,890.43 - 2,911.17|
|52 Week Range||2,488.03 - 2,916.50|
Investing.com - The S&P 500 closed higher on Tuesday as softer-than-expected tariffs imposed by the U.S. and China put the brakes on the prospect of a full-blown trade war, prompting a wave of buying across stocks.
Tilray CEO Brendan Kennedy shares his take on the future of medical and recreational marijuana with CNBC's Jim Cramer. Kennedy tells the "Mad Money" host that drug and alcohol makers should turn their focus to companies like his. Pharmaceutical companies have to start thinking about partnering with cannabis companies as a "hedge" against the burgeoning marijuana industry, Tilray TLRY CEO Brendan Kennedy told CNBC on Tuesday.
Jim Cramer sits down with Tilray CEO Brendan Kennedy to get his take on the future of medical and recreational marijuana.
A steady stream of robust earnings and economic data has virtually zapped volatility from U.S. stocks, but a coming freeze on share buybacks could challenge the market.
On a day stocks rose in spite of new tariff moves, FedEx fell after reporting disappointing profits and Viking Therapeutics announced surprisingly strong results from a drug trial.
In the week that ended on September 7, US crude oil inventories fell 3% below their five-year average. In the previous week, inventories were on par with their five-year average.